How Does This Software Platform Operate?
Veeva Systems builds software used by life sciences companies to manage customer relationships, content, and regulated workflows. Its products are designed for enterprise deployments where compliance and repeatable processes matter. The company sells subscriptions and related services tied to implementing and running its applications. It operates at global scale, serving large organizations with ongoing software needs.
Are Growth and Margins Holding Steady?
FundamentalsFor the year ended January 31, 2026 (reported in USD), Veeva held USD 1.4 billion of cash on the balance sheet, alongside USD 3.2 billion of revenue. EBIT was USD 916.4 million and net income was USD 908.9 million, with trailing margins that remain high at a 75.53% gross margin, 28.68% operating margin, and 28.44% net profit margin.
Revenue grew 16.3% versus the prior annual period, while the cash flow proxy was USD 668.7 million. Depreciation and amortization totaled USD 38.0 million, keeping the earnings profile relatively clean in the context of the reported figures.
Is the Market Paying Too Much Now?
DCF / MultiplesAt USD 188.66 per share, the stock sits above the central DCF estimate of USD 150.09, while still below the stronger-case value of USD 226.34 and above the weaker-case value of USD 91.69. The current pricing also lines up with a 31.30x trailing P/E and 29.17x EV/EBITDA, with an 8.90x price-to-sales multiple.
Quality Priced for Stability
TakeawayThe business looks durable, but the price leans on that durability. Cash provides a real buffer against operating surprises. High margins help resilience when growth cools. The setup weakens if growth fades without cash compounding. The biggest risk is paying up for stability.